News

FDA flags problems with two Boston Scientific heart devices tied to injuries and deaths

U.S. health officials have issued warnings on two separate Boston Scientific heart devices recently linked to injuries and ...
MedPage Today1h

FDA Approves Brain Tumor Drug Targeting New Mutation

The FDA granted accelerated approval to dordaviprone (Modeyso) as the first systemic therapy for adults and children with ...

US FDA approves Jazz Pharma's drug for rare brain tumor

The U.S. Food and Drug Administration said on Wednesday that it has approved Jazz Pharmaceuticals' drug to treat diffuse ...

FDA Approves Vizz Eye Drops to Improve Near Vision in Adults

Vizz is the first and only aceclidine-based eye drop to improve near vision in adults with presbyopia. Vizz contracts the ...

Nationwide sweetener recall update as FDA issues risk warning

NuNaturals, Inc. initiated a voluntary recall for select lots of its Organic Pure Stevia and Pure Monk Fruit Sweetener on ...
Targeted Oncology3h

Dordaviprone Receives Accelerated FDA Approval for Diffuse Midline Glioma

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...
CURE3h

FDA Approves Modeyso for Patients with Diffuse Midline Glioma

The U.S. FDA granted accelerated approval to Modeyso for the patients with diffuse midline glioma with an H3 K27M mutation ...
The American Journal of Managed Care1h

FDA Approves Dordaviprone as First and Only Treatment for Aggressive Form of Glioma

Dordaviprone (Modeyso) is now approved to treat recurrent H3 K27M-mutant diffuse midline glioma, an ultra-rare, aggressive ...
Fierce Pharma3h

Jazz's Modeyso becomes first FDA-approved drug for type of aggressive brain cancer

When Jazz Pharmaceuticals' incoming CEO Renee Gala takes the reins at the drugmaker next week, she'll have a brand new launch ...

FDA Issues Highest Risk Warning For Nuts

Navarro Pecan Holdings, LLC issued a voluntary recall of 32,670 pounds of pecan products on July 10 due to concerns about ...

Vertex falls after FDA doubts broad use of chronic pain drug

Vertex Pharmaceuticals Inc. fell after an experimental pain drug failed to provide post-surgery benefits and US regulators ...

The FDA is targeting orange juice. Here’s why, and what the science says.

Orange juice, known for its tangy, sweet taste, could be made with slightly less sugary oranges under a regulation proposed ...